Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trial (Q36410111)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trial |
scientific article |
Statements
1 reference
Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trial (English)
1 reference
Jacobus Burggraaf
1 reference
Eveline P van Poelgeest
1 reference
Michael R Hodges
1 reference
Matthijs Moerland
1 reference
Yann Tessier
1 reference
Arthur A Levin
1 reference
Robert Persson
1 reference
Marie W Lindholm
1 reference
Kamille Dumong Erichsen
1 reference
Henrik Ørum
1 reference
Adam F Cohen
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference